Different Mechanisms for Impaired Fasting Glucose and Impaired Postprandial Glucose Tolerance in Humans A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

OBJECTIVE—To compare the pathophysiology of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) in a more comprehensive and standardized fashion than has hitherto been done. RESEARCH DESIGN AND METHODS—We studied 21 individuals with isolated IFG (IFG/normal glucose tolerance [NGT]), 61 individuals with isolated IGT (normal fasting glucose [NFG]/IGT), and 240 healthy control subjects (NFG/NGT) by hyperglycemic clamps to determine first- and second-phase insulin release and insulin sensitivity. Homeostasis model assessment (HOMA) indexes of β-cell function (HOMA-%B) and insulin resistance (HOMA-IR) were calculated from fasting plasma insulin and glucose concentrations. RESULTS—Compared with NFG/NGT, IFG/NGT had similar fasting insulin concentrations despite hyperglycemia; therefore, HOMA-IR was increased ∼30% (P < 0.05), but clamp-determined insulin sensitivity was normal (P > 0.8). HOMA-%B and first-phase insulin responses were reduced ∼35% (P < 0.002) and ∼30% (P < 0.02), respectively, but second-phase insulin responses were normal (P > 0.5). NFG/IGT had normal HOMA-IR but ∼15% decreased clamp-determined insulin sensitivity (P < 0.03). Furthermore, HOMA-%B was normal but both first-phase (P < 0.0003) and second-phase (P < 0.0001) insulin responses were reduced ∼30%. IFG/NGT differed from NFG/IGT by having ∼40% lower HOMA-%B (P < 0.012) and ∼50% greater second-phase insulin responses (P < 0.005). CONCLUSIONS—Since first-phase insulin responses were similarly reduced in IFG/NGT and NFG/IGT, we conclude that IFG is due to impaired basal insulin secretion and preferential resistance of glucose production to suppression by insulin, as reflected by fasting hyperglycemia despite normal plasma insulin concentrations and increased HOMA-IR, whereas IGT mainly results from reduced second-phase insulin release and peripheral insulin resistance, as reflected by reduced clamp-determined insulin sensitivity.

[1]  H. Woerle,et al.  Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values. , 2004, Archives of internal medicine.

[2]  A. Karter,et al.  Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. , 2004, Diabetes.

[3]  H. Kuroki,et al.  Who are more insulin resistant, people with IFG or people with IGT? , 2004, Diabetologia.

[4]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[5]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[6]  Ambady Ramachandran,et al.  Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians , 2003, Diabetes/metabolism research and reviews.

[7]  M. Hanefeld,et al.  Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. , 2003, Diabetes care.

[8]  Piero Marchetti,et al.  Phasic insulin release and metabolic regulation in type 2 diabetes. , 2002, Diabetes.

[9]  Kwang‐Won Kim,et al.  Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. , 2001, Metabolism: clinical and experimental.

[10]  T. Jenssen,et al.  Relative conributions of beta-cell function and tissue insulin sensitivity to fasting and postglucose-load glycemia. , 2000, Metabolism: clinical and experimental.

[11]  M. Davies,et al.  Impaired glucose tolerance and fasting hyperglycaemia have different characteristics , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[12]  L. Groop,et al.  Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. , 2000, Diabetes.

[13]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[14]  C Meyer,et al.  Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism. , 1998, The American journal of physiology.

[15]  H. Yki-Järvinen,et al.  Insulin Secretion and Insulin Sensitivity in People with Impaired Glucose Tolerance , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[16]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[17]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[18]  R. Rizza,et al.  Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. , 1992, The New England journal of medicine.

[19]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[20]  P. Bratusch-Marrain.  [The euglycemic insulin and hyperglycemic clamp technic. Methods for the determination of insulin sensitivity of tissues and glucose sensitivity of the B cell. A review]. , 1984, Infusionstherapie und klinische Ernahrung.

[21]  N. Abumrad,et al.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. , 1981, Metabolism: clinical and experimental.

[22]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.